UCL

Cambridge Enterprise 6 September 2023

Pioneering portfolio company Apollo Therapeutics closes $226.5 million round to translate fundamental medical research into medicines

Find out more
Annual Review 3 August 2023

Developing policy structures to help the UK maximise impact from research

Find out more
Cambridge Enterprise 24 April 2023

Leading universities and VCs publish unique USIT Guide to accelerate university spin-outs and boost UK growth

Find out more
Ventures 7 November 2022

Cambridge spin-out raises £4.2m to tackle gigatonnes of emissions from highly pollutive cement industry

Find out more
Industry 1 March 2022

Apollo Therapeutics: KE Award Winners

Find out more
Physical Sciences 30 November 2021

EMIT Consortium consultancy opportunity

Find out more
Ventures 20 October 2021

Cambridge Enterprise invests in Carbon Re, start-up cutting CO₂ emissions by gigatonnes

Find out more
Cambridge Enterprise 17 June 2021

Apollo Therapeutics launches as multinational company, backed by £100m investment

Find out more
Cambridge Enterprise 18 September 2020

Top US, UK, and EU universities work together to help economies fuel post-COVID recovery

Find out more
Life Sciences 9 February 2016

Apollo: industry expertise and pharma muscle drives science to the clinic with unparalleled speed

Find out more
Life Sciences 25 January 2016

Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation

Find out more
Technology Transfer 16 May 2013

UCL and Cambridge share in £50m of new funding to help UK economy

Find out more